Clarivate Plc (CLVT) Stock

Clarivate Plc operates as a prominent information services and analytics company, specializing in delivering structured insights and analytics crucial for the discovery, protection, and commercialization of scientific research, innovations, and brands globally. The company's comprehensive portfolio includes renowned products and services designed to empower organizations throughout the research lifecycle.

Clarivate's flagship Web of Science platform provides essential tools like InCites, Journal Citation Reports, EndNote, ScholarOne, Converis, Publons, and Kopernio. These tools cater to entities involved in planning, funding, executing, and leveraging research efforts across various sectors. In the life sciences domain, Clarivate offers Cortellis and Newport Integrity, aiding pharmaceutical and biotechnology firms in research support, market intelligence, and competitive analysis during drug development and commercialization.

The company's Derwent suite comprises Derwent Innovation, Techstreet, and IP Professional Services, enabling clients to assess product novelty, secure patent rights, navigate competitive landscapes, and ensure compliance with industry standards. Additionally, its CompuMark offerings provide trademark screening, searching, and monitoring services crucial for businesses and law firms, while MarkMonitor solutions assist enterprises in managing and safeguarding their online presence.

With a global presence, Clarivate serves a diverse clientele including government agencies, academic institutions, life sciences firms, and research and development corporations across the Americas, Europe, Asia Pacific, Middle East, and Africa. Formerly known as Clarivate Analytics Plc, the company rebranded as Clarivate Plc in May 2020 and is headquartered in London, United Kingdom, positioning itself as a trusted partner in the pursuit of knowledge and innovation worldwide.